Hilo Raises $19 Million and Launches Wearable Blood Pressure Monitor in the US
Share this article
Hilo has launched Hilo Core, a wearable system designed to give people long-term blood pressure insights instead of one-off cuff readings. The company, based in Neuchâtel, Switzerland, is bringing the device to the US market starting today, available via Hilo.com and Amazon.
Hilo Core pairs a lightweight wrist band with a mobile app and an FDA-cleared connected cuff. Using optical sensor technology and photoplethysmographic (PPG) signals at the wrist, it takes 30-35 readings a day, including overnight, and cross-references them with sleep, steps, and heart rate. Periodic cuff readings calibrate and validate the wearable’s estimates, so the system delivers trend data over time rather than a single snapshot. Hilo says the underlying technology has been validated in eight clinical studies and used by more than 200,000 people globally.
The US launch comes on the heels of a $19 million extension to Hilo’s Series B, led by Dell Family Office, bringing total funding to over $119 million. The Swiss Health Valley company had already raised $42 million in its original Series B round last year.
Stefan Petzinger, CEO of Hilo by Aktiia, said:
“Hilo represents a fundamental shift in how we approach blood pressure, especially in the U.S., where nearly half of adults live with hypertension and many remain undiagnosed or undertreated. For too long, blood pressure has been measured in isolated moments, leaving critical gaps in understanding. By moving to long-term, real-world insights, we’re empowering people and their care teams to take earlier, more informed action and fundamentally change how cardiovascular health is managed. And not only does Hilo provide a more comprehensive view it also puts less daily dependency on the inflatable cuff, a technology developed in 1881 that is not exactly most convenient and comfortable in day-to-day life. ”
➡️ Source: Press Release | 📸 © Hilo